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Activity of Carcinogens That Bind to the C8
Position of Guanine Residues in an Assay
Specific for the Detection of -2 Frameshift
Mutations in a Defined Hot Spot
by Robert P. P. Fuchs* and Regine Bintz*
Inthis paperwedescribe areversionassay specific forthedetection of-2frameshiftmutationsoccurring
within short stretches of alternating GC sequences. We have compared a series of chemical carcinogens
that all bind covalently to the C8 position ofguanine residues for their potency in inducing revertants in
this assay. Large variations in potency are found within the list ofcompounds that were tested. The most
potent chemicals tested induce the reversion frequency by afactor of10 overbackground, whereas others
only increase itby twoorders ofmagnitude. Thesedifferences arediscussed in termsoftheconformational
changes that the different C8-guanine adducts induce in DNA.
Introduction
The ultimate carcinogen N-acetoxy-N-2-acetylami-
nofluorene (N-Aco-AAF), a model for the strong liver
carcinogenN-2-acetylaminofluorene (AAF), binds cova-
lently to DNA, yielding primarily -AAF adducts at the
C8 position of guanine (1). The spectrum of mutations
induced by -AAF adducts in E. coli has been studied
in our laboratory using a forward mutation assay based
on inactivation of the tetracycline resistance gene car-
ried by plasmid pBR322 (2,3). More than 90% of the
mutations induced by -AAF adducts are frameshift mu-
tations, and many of them are located at specific se-
quences, the so-called mutation hot spots (2,3).
Two classes ofmutation hot spots have been defined
on the basis ofthe local sequence where they occur: a)
-1 frameshift mutations within runs of guanines: In-
duction of mutations within such sequences requires a
functional umuDiC locus (3) and can be ascribed to a
slipped-strand mispairing event occurring during rep-
lication (4). This pathway is referred to as the slippage
pathway. b) -2 frameshift mutations within short
stretches of alternating GC sequences: This mutation
pathway wasoriginally discovered attheNarI sequence
(GGCGCC -* GGCC) (2) and extended to other se-
quences such as the BssHII sequence (5). The induction
of mutations within these sequences is UmuDIC inde-
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pendent (3). This pathway is referred to as the NarI
mutation pathway. Additional differences ingenetic re-
quirements of the two pathways have recently been
reported (6).
Because we were interested in the mechanisms that
are involved in the NarI mutation pathway, we devel-
oped a reversion assay specific for the detection of -2
frameshift mutations within short stretches of alter-
nating GC sequences (5,7). This assay has been used to
compare the mutagenic potency of several bulky car-
cinogens that are known to bind covalently to the C8
positionofguanineresidues. Therearelargedifferences
in the potency with which the chemicals induce -2
frameshift mutations. These results are discussed in
terms of the conformational changes that are induced
in the DNA helix upon binding of the chemicals.
Design of a Mutation Assay Specific
for Detecting -2 Frameshift
Mutations within Alternating GC
Sequences
The mutation assay is based upon the reversion of a
specific mutation that inactivates the tetracycline re-
sistance gene carried on plasmid pBR322 (5). The re-
version event calls for the loss of two base pairs (CpG
or GpC dinucleotide) located within a GCGCGC se-
quence in order to restore the wild-type sequence of
the tetracycline resistance gene (Fig. 1). The target for
the mutation assay is located on a multicopy plasmid
pX2 derived from pBR322. This plasmid contains two84 FUCHS AND BINTZ
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FIGURE 1. Strategy ofthe reversion assay specific forthe detection
of-2frameshift mutations within short alternating GC sequences.
Plasmid pX2 contains a unique BssHII site that was created in
the tetracycline resistance gene of pBR322 by insertion of a GC
dinucleotide. As a consequence, the tetracycline resistance gene
is inactivated. Plasmid pX2 reverts to wild-type plasmid pBR322
by the specific loss oftwo base pairs within the BssHII site. Rev-
ertants are selected on the basis of their growth on tetracycline-
containing plates. They can be characterized further at the mo-
lecular level by restriction enzyme analysis (i.e., loss ofthe unique
BssHII site).
additional base pairs (GpC) inserted by genetic engi-
neering between base pairs 435 and 436 within a NarI
site in the tetracycline resistance gene (5). Its pheno-
type is ampicillin resistant, tetracycline sensitive. This
plasmid is stably maintained in E. coli strains by se-
lectivegrowth onplates containingampicillin. Theassay
detects plasmids that have undergone the specific loss
of the two additional base pairs to yield the wild-type
tetracycline resistance gene. Sincethemutational event
is umuD/C independent (3,5) and occurs by the specific
loss oftwo base pairs within a short run of alternating
GC sequences, it isrepresentative oftheNarImutation
pathway. The selection is based on the ability of the
revertant to grow on plates containing tetracycline. In
this assay, the product ofthe reversion event is a dom-
inant allele, and the target is multiple since pBR322 is
a multicopy plasmid (average of 20 copies per bacter-
ium).
Restriction enzyme analysis ofthe plasmid DNA con-
tained in a collection of individual revertant colonies
obtained after treatment with mutagens showed that
the tetracycline-resistant phenotype was associated
with the loss ofthe BssHII restriction site (Fig. 1) (7).
This result indicates that the mutation assay is indeed
specific for the detection of -2 frameshift mutations
within a short alternating GC sequence.
Chemical Carcinogens That Bind
Covalently to the C8 Position of
Guanine Residues
We have selected several chemical carcinogens (Fig.
2) known to form covalent adducts at the C8 position of
guanine residues in order to compare their mutagenic
potency in inducing -2 frameshift mutations in a se-
quence ofalternating GC base pairs.
Compound I, II, III and IV (Fig. 2) are reactive de-
rivatives ofthe aromatic amine AAF, a strong rat liver
carcinogen. All four compounds are known to form the
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FIGURE 2. Chemical carcinogens used in this study. I, N-Acetoxy-
N-2-acetylaminofluorene (N-AcO-AAF); II, N-acetoxy-N-2-ace-
tylamino-7-fluorofluorene (N-AcO-AAFF); III, N-acetoxy-N-2-
acetylamino-7-iodofluorene (N-AcO-AAIF); IV, N-hydroxy-N-2-
aminofluorene (N-OH-AF); V, N-acetoxy-N-3-acetylamino-4,6-di-
methyldipyrido(1,2-a: 3,2'-d)imidazole (N-AcO-AGluP3); VI, 2-ni-
tro-3-methylimidazo(4,5-f)quinoline (NO2-IQ); VII, 4-nitroquino-
line-i-oxide (NQO).
majority oftheir adducts at the C8 position ofthe guan-
ine residues in DNA (80 to 95% of the total adducts
formed) (1,8-10).
Compound V andVI (Fig. 2) bothbelongtothefamily
ofso-called food mutagens (11), which form during pyr-
olysis of proteins. Compound V, N-AcO-AGluP3, is a
model ultimate metabolite (12) ofthe parent compound
GluP3, a chemical found in pyrolysates of L-glutamic
acid (13). Compound VformsmostlyC8guanineadducts
(12). Compound VI, N02-IQ, is the nitro derivative of
IQ, a strong mutagen found in the charred surface of
fish and beefsteak (14). N02-IQ does not react chemi-
cally with DNA as such but requires metabolic activa-
tioninvivo. IthasbeenproposedthatactivationofNO2-
IQtoachemicallyreactivemutageninbacteriaproceeds
via a nitroreductase-catalyzed step followed by a an 0-
acetyltransferase-catalysed step (15).
Compound VII, 4-NQO, is another carcinogenic nitro
compound (16) thatrequires metabolic activation, prob-
ably by the same route as N02-IQ. In vivo, NQO is
known to form several adducts whose relative propor-CHEMICAL CARCINOGENS INDUCE FRAMESHIFT MUTATION HOT SPOTS
tions (17) are as follows: N2 position ofguanine (50%),
C8 of guanine (30%), and N6 of adenine (15%).
Comparative Mutagenic Potency of
Chemical Carcinogens That Bind
Covalently to the C8 Position of
Guanine Residues
Several chemical carcinogens (Fig. 2) known to bind
covalently to position C8 of guanine residues in DNA
were tested for their potential to induce -2 frameshift
mutations in the assay described above. Since the NarI
mutation pathway is umuD/C independent (3,5), we
performed the mutation experiments in strain GW2100,
a umuC mutant (18). Plasmid pX2, which carries the
target for the mutation assay, was introduced by a
transformation step into a permeable derivative of
strain GW2100 (7) and stably maintained in this strain
by growth in media containing ampicillin. The use of a
permeable derivative of strain GW2100 was necessary
to allow the penetration ofthe chemicals.
Briefly, the protocol for the mutation assay is as fol-
lows. Log-phase bacteria are treated for30mininphos-
phate buffer with several concentrations of the test
chemical dissolved indimethyl sulfoxide orethanol(final
concentration 5%). After treatment, the bacteria are
plated on ampicillin plates for determining numbers of
survivors and grown at 37°C for a 90 min expression
period before plating on tetracycline plates for deter-
mining numbers of revertants.
Large differences in reversion frequencies are found
among the chemicals tested (Table 1). The background
reversion frequency is low (= 5 x 10-9). The curve of
reversion frequency versus concentration formost-eom-
poundshas abroadmaximum(datanotshown). Inorder
to comparethemutagenic potencyofthedifferentchem-
icals, we have defined amutationinductionfactor(MIF)
as the ratio of the maximal reversion frequency for a
given mutagen over the background reversion fre-
quency (Table 1). The concentration of the mutagen
needed to achieve the maximalreversion frequency and
survival at this dose are reported in Table 1.
Although all the mutagens that we tested bind cov-
alently to the C8 ofguanine residues, they exhibit very
different mutagenic potencies. Three mutagens (N-
AcO-AAF, N-AcO-AAFF, and N02-IQ) appeared to be
extremely efficient (MIF : 50000) in this assay. Two
chemicals (N-AcO-AGluP3 and NQO) had low efficiency
(MIF s- 300), and two chemicals (N-AcO-AAIF and N-
OH-AF)hadintermediate efficiency(MIFbetween 1000
and 5000).
The chemical concentration at the maximal reversion
frequency ranged from 5 x 10-5 M (N-OH-AF) to 2
X 10-3 M (N-AcO-AGluP3), possibly reflecting differ-
ences in reactivity with the medium and or with the
DNA, penetration into the cells, and metabolism. Sur-
vival at the maximal reversion frequency was about 2
to 8% except for N-OH-AF and N-AcO-AGluP3, which
were less toxic (: 50% survival).
Relationship between Mutagenic
Potency and Local Conformation of
the Adduct
A forward mutation assay based on the inactivation
of the tetracycline resistance gene on plasmid pBR322
was developed in our laboratory several years ago (2).
In this assay, covalent adducts are formed in the plas-
mid DNA by treatment with a mutagen in vitro, and
the modified plasmids are introduced into SOS-induced
bacteria. Among the transformants selected on ampi-
cillin containing plates, tetracycline sensitive mutants
are detected by their inability to grow on plates con-
tainingtetracycline (19). Usingthis assay, AAFadducts
werefound tobe veryefficientininducing-2frameshift
mutations at the NarI site in pBR322 (3). Indeed,
among the mutants sequenced in this forward mutation
assay, a high proportion (i.e., 12/36 = 33%) are -2
frameshift mutants occurring at one ofthe three NarI
sites in the mutation target (Table 2). With the same
assay, AF adducts (20) and AAIF adducts (21) were
found to induce NarI mutations, but at a lower fre-
quency (Table 2). On the other hand, no -2 frameshift
mutations were detected among a similar number of
mutationsinducedbyNQO (P. Daubercies, S. Galiegue-
Zouitana, M.-H. Loucheux, and B. Bailleul, personal
communication) or AGluP3 adducts (22) (Table 2).
Therefore, there is qualitative agreement between the
efficiency of a mutagen in inducing NarI mutations in
the forward mutation assay and in inducing reversions
Table 1. Relative potency in inducing -2 frameshift mutations in alternating GC sequences.
Concentration at Survival at
Maximal reversion maximal reversion maximal reversion
Compound frequency frequency frequency, % MIF"
N-AcO-AAF(I) 2-3 x 10-4 3 x 10-4M 8 50,000
N-AcO-AAFF(II) 2-3 x 10-4 3 x 10-4M 2 50,000
N-AcO-AAIF(III) 2-3 x 10-5 5 x 10-4M 3 5,000
N-OH-AF(IV) 6x 10-6 5 x 10-5M 50 1,200
N-AcO-AGluP3(V) 1-2 x 10-6 1-2 x 10-3M 40 300
NQO (VII) 8x10-7 2-3 x 10-4M 6 "-160
N02-IQ (VI) 1-2 x 10 - 4 x 104M 1.5 30,000
aThe mutation induction factor (MIF) is defined as the ratio of the maximal reversion frequency over the background reversion frequency
(5 x 10-9).
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Table 2. Correlation between the induction ofNarl mutations
and local conformation ofthe adducts.
Number of Total Proportion of anti -- syn
Narl number of Narl or B -* Z
Adduct mutants mutants mutantsa conversionb
AAF 12 36 33% + + +
AF 2 23 9% +
AAIF 1 24 4% +
AGluP3 0 26 <4% + + +
NQO 0 31 <3% -
aARi data are obtained in strain AB1157 except for AAF, which is
a compilation of data obtained in the strain AB1157 and an isogenic
uvrA strain (AB1886).
b+ + +) anti to syn conformation or B to Z transition is highly
favored; (+) anti to syn conformation or B to Z transition is slightly
favored; (-) anti to syn conformation or B to Z transition is not
favored.
in the assay described in this paper. The assays differ
in important respects: forward mutations versus rever-
sions and in vitro versus in vivo treatment of the mu-
tationtarget. Nevertheless, thedatafromthereversion
assay permit the prediction that N02-IQ would be ef-
ficient in inducing NarI mutations in the forward mu-
tation assay.
Single adduct mutagenesis experiments have shown
that NarI mutagenesis results from the processing of
an AAF adduct bound specifically to the internal guan-
ine residue ofthe NarI sequence (23). Circular dichro-
ism spectra of short helices containing the NarI site
have indicated that binding of AAF adducts to the in-
ternal guanine residue induces a local Z-DNA-like con-
formation(24). Wehavehypothesizedthatthe-2frame-
shift event results from the processing of this Z-like
conformation (3,23). In the cascade ofevents leading to
theconversionofasmallalternatingCpGsequencefrom
the B to the Z conformation, one can distinguish two
steps: the anti to syn conversion ofthe guanine residue
and the conformational change of the phosphate-sugar
backbone from the B type to the Z type conformation.
In this scheme, the driving force is the conversion of
the guanine residue from anti to syn. At least two con-
ditions have to be met to produce local Z-DNA struc-
tures within B-DNA: the anti to syn conversion of a
guanine residue triggered by covalent binding to C8,
and a proper sequence context in the neighborhood of
the adducted guanine (i.e., alternating CpG or TpG se-
quences). The local sequence requirements are notfully
clear, however, since there might also be a sequence
requirement for the formation ofthe two B/Z junctions
that exists when a Z-like region is surrounded by B-
DNA.
It is tempting to relate the ability of a C8-G adduct
to trigger the anti to syn conformational change to its
efficiency in inducing -2 frameshift mutations within
short alternating CpG sequences (Table 2). NMR and
CD studies have shown the AAF and AAFF adducts,
but not AAIF nor AF adducts, favor the anti to syn
conversion of the adducted guanine residue (8,10).
Moreover, it has been shown that AAF and AGluP3
adducts facilitate the B to Z conversion ofmodified poly
dCpG (25-27). Onthe otherhand, AFand NQO adducts
have little or no effect on the B to Z conversion of
modified poly dCpG (25,28). Therefore, the data cur-
rently available tend to support our hypothesis that the
induction of -2 frameshift mutations is related to the
changes from anti to syn and from the B-conformation
to the Z-conformation. AGluP3 appears to be an excep-
tion in that it is efficient in promoting the B to Z con-
version (27) but poor in inducing NarI type mutations
in the reversion assay (22). A possible explanation for
this discrepancy is that deacetylation of AGluP3 ad-
ducts, which has been reported to occurinthe presence
of divalent ions such as Zn2+ or Co2", leads to the for-
mation of GluP3 adducts rather than AGluP3 (12). By
analogy to the differences between AAF and its deace-
tylated form AF (3,20,25), these deacetylated GluP3
adducts would be expected to induce neither the B to
Z transition northe -2frameshift mutations. Forsteric
reasons, the presence of an N-acetyl group appears to
be critical in favoring the anti to syn conversion in the
case ofC8-AAF adducts, and perhaps forN-arylamine-
C8-guanine adducts in general.
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